Suppr超能文献

液泡型ATP酶依赖性溶酶体酸化在心血管疾病中的新作用

The Emerging Roles of Vacuolar-Type ATPase-Dependent Lysosomal Acidification in Cardiovascular Disease.

作者信息

Chen Yan-Yan, Liu Cai-Xia, Liu Hai-Xin, Wen Shi-Yuan

机构信息

School of Medicine, Jiangsu University, Zhenjiang 212013, China.

College of Traditional Chinese Medicine and Food Engineering, Shanxi University of Chinese Medicine, Taiyuan 030024, China.

出版信息

Biomolecules. 2025 Apr 3;15(4):525. doi: 10.3390/biom15040525.

Abstract

The vacuolar-type ATPase (V-ATPase) is a multi-subunit enzyme complex that maintains lysosomal acidification, a critical process for cellular homeostasis. By controlling the pH within lysosomes, V-ATPase contributes to overall cellular homeostasis, helping to maintain a balance between the degradation and synthesis of cellular components. Dysfunction of V-ATPase impairs lysosomal acidification, leading to the accumulation of undigested materials and contributing to various diseases, including cardiovascular diseases (CVDs) like atherosclerosis and myocardial disease. Furthermore, V-ATPase's role in lysosomal function suggests potential therapeutic strategies targeting this enzyme complex to mitigate cardiovascular disease progression. Understanding the mechanisms by which V-ATPase influences cardiovascular pathology is essential for developing novel treatments aimed at improving outcomes in patients with heart and vascular diseases.

摘要

液泡型ATP酶(V-ATP酶)是一种多亚基酶复合物,它维持溶酶体酸化,这是细胞稳态的一个关键过程。通过控制溶酶体内的pH值,V-ATP酶有助于整体细胞稳态,帮助维持细胞成分降解与合成之间的平衡。V-ATP酶功能障碍会损害溶酶体酸化,导致未消化物质的积累,并引发各种疾病,包括动脉粥样硬化和心肌疾病等心血管疾病(CVD)。此外,V-ATP酶在溶酶体功能中的作用提示了针对这种酶复合物的潜在治疗策略,以减轻心血管疾病的进展。了解V-ATP酶影响心血管病理的机制对于开发旨在改善心脏和血管疾病患者预后的新疗法至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18f9/12024769/745c997ff3dc/biomolecules-15-00525-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验